Kezar Life Sciences Inc. (NASDAQ: KZR)
$7.5450
-0.0750 ( +0.60% ) 21.4K
Kezar Life Sciences Inc is a clinical-stage biotechnology company. It is engaged in discovering and developing novel small molecule therapeutics to treat unmet needs in autoimmunity and cancer. The pipeline consist of product candidates such as Zetomipzomib (KZR-616), and KZR-261.
Market Data
Open
$7.5450
Previous close
$7.6200
Volume
21.4K
Market cap
$55.38M
Day range
$7.3100 - $7.6200
52 week range
$5.2020 - $11.3500
SEC Filings
| Form Type | Description | Pages | Date |
|---|---|---|---|
| 8-k | 8K-related | 11 | Nov 14, 2024 |
| 10-q | Quarterly Reports | 77 | Nov 12, 2024 |
| 8-k | 8K-related | 12 | Nov 12, 2024 |
| 8-k | 8K-related | 13 | Oct 28, 2024 |
| 8-k | 8K-related | 19 | Oct 17, 2024 |
| 8-k | 8K-related | 12 | Oct 10, 2024 |
| 8-k | 8K-related | 12 | Oct 04, 2024 |
| 8-k | 8K-related | 12 | Sep 30, 2024 |
| 10-q | Quarterly Reports | 77 | Aug 13, 2024 |
| 8-k | 8K-related | 12 | Aug 13, 2024 |